- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological treatment of trigeminal neuralgia
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume 17, Issue 10, Pages 1003-1011
Publisher
Informa UK Limited
Online
2017-08-22
DOI
10.1080/14737175.2017.1370375
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial
- (2017) Joanna M Zakrzewska et al. LANCET NEUROLOGY
- Efficacy of intravenous lidocaine and magnesium in intractable trigeminal neuralgia: A preliminary report
- (2016) Min Xu et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Trigeminal neuralgia
- (2016) Giorgio Cruccu et al. NEUROLOGY
- Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool Adverse Events Profile (AEP)
- (2015) E. Besi et al. JOURNAL OF HEADACHE AND PAIN
- Botulinum neurotoxin type A in the treatment of classical Trigeminal Neuralgia (BoTN): study protocol for a randomized controlled trial
- (2015) Jan Burmeister et al. Trials
- Intravenous fosphenytoin for acute exacerbation of trigeminal neuralgia: case report and literature review
- (2015) Alejandro Vargas et al. Therapeutic Advances in Neurological Disorders
- Intravenous Lidocaine Treatment in Classical Trigeminal Neuralgia With Concomitant Persistent Facial Pain
- (2014) Priyanka Chaudhry et al. HEADACHE
- Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial
- (2014) Haifeng Zhang et al. JOURNAL OF HEADACHE AND PAIN
- Therapeutic effect of Botulinum toxin-A in 88 patients with Trigeminal Neuralgia with 14-month follow-up
- (2014) Shuang Li et al. JOURNAL OF HEADACHE AND PAIN
- Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain
- (2014) Giulia Di Stefano et al. JOURNAL OF HEADACHE AND PAIN
- Immediate Analgesic Effect of 8% Lidocaine Applied to the Oral Mucosa in Patients with Trigeminal Neuralgia
- (2014) Yuriko Niki et al. PAIN MEDICINE
- The International Classification of Headache Disorders, 3rd edition (beta version)
- (2013) CEPHALALGIA
- Acute Treatment of Trigeminal Neuralgia With Onabotulinum Toxin A
- (2013) Carlos Zúñiga et al. CLINICAL NEUROPHARMACOLOGY
- Intravenous lidocaine and magnesium for management of intractable trigeminal neuralgia: a case series of nine patients
- (2013) Young-Chang P. Arai et al. Journal of Anesthesia
- Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia?
- (2013) Hatem S Shehata et al. JOURNAL OF HEADACHE AND PAIN
- Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial
- (2012) Chuan-Jie Wu et al. CEPHALALGIA
- Refractory Trigeminal Neuralgia
- (2012) Giorgio Cruccu et al. CNS DRUGS
- Misoprostol as a Therapeutic Option for Trigeminal Neuralgia in Patients with Multiple Sclerosis
- (2012) Giselher Pfau et al. PAIN MEDICINE
- Treatment of refractory trigeminal neuralgia with intravenous phenytoin
- (2011) R. Tate et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Lamotrigine for trigeminal neuralgia: Efficacy and safety in comparison with carbamazepine
- (2011) Sameer Shaikh et al. Journal of the Chinese Medical Association
- Management of pain in multiple sclerosis: a pharmacological approach
- (2011) Claudio Solaro et al. Nature Reviews Neurology
- EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
- (2010) N. Attal et al. EUROPEAN JOURNAL OF NEUROLOGY
- An Observational Trial to Investigate the Efficacy and Tolerability of Levetiracetam in Trigeminal Neuralgia
- (2010) Dimos D. Mitsikostas et al. HEADACHE
- Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report
- (2010) Behnam Bohluli et al. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS
- Treatment options in trigeminal neuralgia
- (2010) Mark Obermann Therapeutic Advances in Neurological Disorders
- Patient-Reported Outcomes in Subjects with Painful Trigeminal Neuralgia Receiving Pregabalin: Evidence from Medical Practice in Primary Care Settings
- (2009) C Pérez et al. CEPHALALGIA
- Gabapentin Supplemented With Ropivacain Block of Trigger Points Improves Pain Control and Quality of Life in Trigeminal Neuralgia Patients When Compared With Gabapentin Alone
- (2009) Laurinda Lemos et al. CLINICAL JOURNAL OF PAIN
- Current Management of Pain Associated with Multiple Sclerosis
- (2009) Walter Pöllmann et al. CNS DRUGS
- Pilot study to evaluate the efficacy and tolerability of levetiracetam (Keppra®) in treatment of patients with trigeminal neuralgia
- (2009) T. P. Jorns et al. EUROPEAN JOURNAL OF NEUROLOGY
- Trigeminal Neuralgia Treated With Pregabalin in Family Medicine Settings: Its Effect on Pain Alleviation and Cost Reduction
- (2009) Concepción Pérez et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pregabalin for treating paroxysmal painful symptoms in multiple sclerosis: a pilot study
- (2009) Claudio Solaro et al. JOURNAL OF NEUROLOGY
- Beneficial effects of botulinum toxin type A in trigeminal neuralgia
- (2008) Carlos Zúñiga et al. ARQUIVOS DE NEURO-PSIQUIATRIA
- Authors' Reply
- (2008) M Obermann et al. CEPHALALGIA
- AAN-EFNS guidelines on trigeminal neuralgia management
- (2008) G. Cruccu et al. EUROPEAN JOURNAL OF NEUROLOGY
- Oxcarbazepine monotherapy in carbamazepine-unresponsive trigeminal neuralgia
- (2008) J.M. Gomez-Arguelles et al. JOURNAL OF CLINICAL NEUROSCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More